SMID Life Science Trades: Its a bull market but harder to pick small cap biotech winners because of volatility…Update-3 GERN,SUPN, XBI.
Update -3 3/17...Risk off continues on small cap Life Science trades. Rotation this week favors Energy (up 3.74%) and Materials (up 1.51%), with S&P 500 and DOW flattish. Notice weakness in all small cap ETFs (IWM) and (IJR) as well as speculative genomics (ARKG) down 13% YTD. If we want...
Healthcare Shares Lag As Investors Get More Bullish, But Volatility Rules….Update-3
Update-3 3/6/2..The XBI huffed and puffed but could not break out from $100 today so my call stands that speculating in SMID biotechs is risk off. The less volatile IBB held near the $138 level. I'll update our trading list at the end of the week but for now here are the SMID biotechs that I...
Investors Try Life in the Slow Lane with Healthcare Stocks…..Update-4 SMID Biotech Rally Fading Already?
3/1/24...Still plenty of good biotech trades around as XBI recovers over 3% to $101.53. Big movers today were: ABOS, CRMD, DNLI, GERN, IMTX, SUPN. https://www.nasdaq.com/market-activity/etf/xbi/advanced-charting 2/29 at close ..MOmentum is easing with volatility making trading more difficult...
Healthcare Stocks Are Looking Better But What About Biotech ?…Update-1
Update-1 2/23/24. You know the story by now it's all about AI and NVDA. As my friend said in the mid -90s "there is no end to chips Rod". Overall one of the best weeks for the market but of course led by technology stocks. The equal weight small cap XBI hit a new 1 yr high at the $95 level but...
Large Cap Biopharmaceuticals: Performance Metrics..Update-1
Update-1..2/15/24...Post from 9/23 biotech bottom when we picked ABBV,GEHC. Near/at new 52 wk. highs : ABBV, LLY, MRK, VRTX, XPH etc. Update- -2/12/24....Gilead Sciences responds immediately to recent trial disappointment to buy CymaBay,a $4.3B deal expanding liver portfolio. See chart below...